AS2 Bio
Pre-clinicalDevelops targeted protein degradation therapies using molecular glues and PROTACs for oncology and other diseases.
Founded
2021
Focus
BiologicsSmall MoleculesViral Technology
About
Develops targeted protein degradation therapies using molecular glues and PROTACs for oncology and other diseases.
Funding History
1Total raised: $5M
Seed$5MUndisclosedJun 15, 2023
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile